高富集团(00263.HK)一名独立非执董被证监会列为应诉人
高富集团(00263.HK)公布,接获一位独立非执行董事黄润权告知,证监会就奇峰国际(已於2020年6月除牌)向香港高等法院原讼法庭提交日期为2020年12月18日之呈请中,彼被列为应诉人之一。
证监会於呈请中指称,该除牌公司的董事(包括黄博士,彼从2007年4月至2010年6月作为独立非执行董事)没有以应尽及合理的谨慎、技能和努力履行彼等作为该除牌公司管理层之职责。
董事会已获黄告知彼不同意证监会在呈请中所作的指称,并将对呈请竭力抗辩。
鉴於该呈请不涉及公司或其任何附属公司及黄亦无参与集团的日常运作,董事会认为该呈请将不会为集团之业务营运或财务状况带来任何重大的不利影响。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.